Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Akebia Therapeutics | AKBA - Modal Pinjaman
Keuangan
Harga Saham
USD
Aktiva
USD 349.66M
Kas Dan Setara
USD 155.55M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 229.55M
Kewajiban Lancar
USD 160.87M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 25.02M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
349.66M
Modal Pinjaman
USD 24.75M
Kapitalisasi Pasar
USD 182.4M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 13.02M
Kreditur Perdagangan
USD 9.42M
Debitur Perdagangan
USD 47.03M
Modal Pinjaman
Perubahan
Tanggal
Acadia Pharmaceuticals
USD 0
0
2025-03
Agios Pharmaceuticals
USD 1.06M
0
2022-09
Akebia Therapeutics
USD 24.75M
11.64M
2026-06
Alnylam Pharmaceuticals
USD 2.47B
6.56M
2026-06
Amgen
USD 51.86B
27M
2026-06
Ardelyx
USD 203.52M
683K
2026-03
Astellas Pharma
JPY 320B
0
2026-06
AstraZeneca
USD 26.01B
46M
2026-06
Bayer
EUR 31.16B
480M
2026-06
BioMarin Pharmaceutical
USD 3.53B
2.1B
2026-06
Celltrion
KRW 411.27B
998.23M
2026-03
Cspc Pharmaceutical
CNY 180.69M
21.94M
2025-12
Deva Holding AS
TRY 559.97M
44.39M
2023-09
Dianthus Therapeutics
USD 0
0
2024-12
Fresenius Medical Care
EUR 5.82B
83.04M
2026-06
GlaxoSmithKline
GBP 13.95B
65M
2026-06
Ionis Pharmaceuticals
USD 1.91B
6.62M
2026-06
Ironwood Pharmaceuticals
USD 583.99M
14.83M
2024-12
J&J
USD 37.34B
183M
2026-06
Kangmei Pharma
CNY 67.35M
1.22M
2026-06
Karyopharm Therapeutics
USD 264.49M
13.73M
2026-03
Knight Therapeutics
CAD 57.78M
26.92M
2025-12
Laboratorios Farma
EUR 80.5M
28.26M
2024-12
Lexicon Pharmaceuticals
USD 49.68M
276K
2026-03
Malin Corporation
EUR 0
0
2024-12
Medical Developments International
AUD 1.5M
167K
2025-12
Moderna
USD 597M
6M
2026-06
Nektar Therapeutics
USD 60.27M
2.89M
2026-03
Organigram Holdings
CAD 60.76M
1.77M
2026-03
Ovoca Bio
EUR 0
0
2021-06
Pharma Mar
EUR 32.13M
1.04M
2026-06
Prothena
USD 0
0
2024-12
PTC Therapeutics
USD 535.52M
248.58M
2026-06
Qiagen NV
USD 1.63B
19.45M
2026-06
Regeneron Pharmaceuticals
USD 1.99B
400K
2026-06
Roche Holding
CHF 25.22B
2.21B
2026-06
Sanofi
EUR 14.65B
806M
2026-06
Sarepta Therapeutics
USD 847.62M
9.46M
2026-06
Sartorius
EUR 3.65B
311.1M
2026-06
Sino Biopharmaceutical
CNY 3.08B
1B
2025-06
Tectonic Therapeutic
USD 17K
26K
2026-03
Tilray
USD 268.59M
3.82M
2025-09
Vanda Pharmaceuticals
USD 3.15M
3.15M
2024-12
Zealand Pharma A/S
307M
76.14M
2026-03
Zz Pientze Pharmaceu
CNY 172.8M
9.49M
2026-06
×